About Careers Internship MedBlog Contact us

Novel Mechanism To Increase The Effectiveness Of New Target-Based Cancer Therapies Developed

by Aruna on September 7, 2009 at 9:59 AM
Novel Mechanism To Increase The Effectiveness Of New Target-Based Cancer Therapies Developed

Researchers in Canada have come across a novel mechanism that may be instrumental in the development of new, more effective cancer therapies.

They have discovered that activation mechanism of the RAF protein kinase which, when mutated, is responsible for more than 25 per cent of cancers.


Understanding this mechanism may lead to novel anti-cancer agents designed to minimize the toxic side effects caused by chemotherapy.

The RAF family of kinases is key in regulating various cellular processes including cell growth, differentiation and survival.

Marc Therrien at the Institute for Research in Immunology and Cancer (IRIC) of the Universiti de Montrial, and Frank Sicheri, at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto claim that dimerization, or combination, of two RAF proteins is essential to its activation.

Inhibiting the dimerization of RAF may therefore block its activation, thus stopping cancer cells from growing.

The study exposes not only the activation mechanism of RAF, but potentially the mechanisms that control other protein kinases, a large number of which are linked to cancer and other diseases such as diabetes, hypertension and neurodegeneration.

"Basic researchers believe that one of the most promising strategies to finding lifelong cures for cancers lies in understanding the molecular underpinnings specific to cancer cells," Nature quoted Therrien as saying.

"It is hoped that this will translate to the development of inhibitors tailored to specific molecular defects and, as a result, should increase the effectiveness of new target-based cancer therapies," he added.

Sicheri said, "protein kinases are the targets for some of the most successful anti-cancer drugs in the clinic."

"Now that we have discovered how to turn off the RAF protein without interfering with other proteins, we may be able to design drugs that have unprecedented precision in targeting cancer cells while reducing the toxic side effects for patients," he added.

Source: ANI
Font : A-A+



Recommended Readings

Latest Cancer News

Breast Reconstruction and Shorter Radiation: The Winning Combo!
Shorter radiation course is just as good as the regular one for women choosing breast reconstruction after mastectomy, saving time and money.
Innovative Cancer Implant Technology Holds Promise to Cut Death Rates by Half
HAMMR's small size permits minimally invasive implantation, monitoring cancer status, and dynamically adjusting immunotherapy, akin to a glucose monitor.
Personalized Vaccine and T Cell Therapy for Ovarian Cancer Patients
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Kinase-Targeted Therapy Revolutionizes Colorectal Cancer Care
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
Novel Photo-Oxidation Therapy Holds Promise for Anticancer Treatment
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Novel Mechanism To Increase The Effectiveness Of New Target-Based Cancer Therapies Developed Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests